The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: ENRC and miners give markets a boost

Fri, 19th Apr 2013 16:33

London's stock markets ended the week on a positive note, finishing with decent gains following a five-day losing streak, with mining stocks doing their best to recover after the recent sell-off.ENRC was a standout performer in the sector, surging by over a quarter by the close on the back of reports that a group of shareholders are working together to mount a takeover bid for the resources giant.Ahead of today's session, the FTSE 100 had lost 2.7% of its value after five consecutive falls as disappointing US earnings and concerns over global growth weighed on sentiment. Miners on the FTSE 350 had fallen by an average 9.14% since last Friday."Clients who went bargain hunting in the mining space after the aggressive sell off earlier in the week have been rewarded today, as the sector bounces back strongly," said Nick Dale-Lace, a Senior Sales Trader at CMC Markets.He said that in the absence of significant macro-economic news today, markets have remained focused on the unfolding man-hunt in Boston."The market has so far shaken off the ongoing terrorist threat, though obviously concerns remain at the forefront of everyone's minds as TV pictures capture the almost unprecedented search," he said.FTSE 100: ENRC rockets on takeover speculationMining stocks, which have borne the brunt of the reduction in risk appetite over the past week, were performing well today. Vedanta, EVRAZ and Fresnillo were high risers by the close.However, it was ENRC that was the standout performer, finishing the day nearly 27% higher after major shareholder Alexander Machkevitch said he was considering a takeover bid for the Kazakh miner. The Jewish billionaire released a statement saying he was seeking a consortium with fellow shareholders Alijan Ibragimov, Patokh Chodiev and the Kazakh government to make an offer for the company. By the close yesterday, the stock had slumped over 19% since the start of the year. Anglo American was also a high riser after announcing that production at its larger operations of iron ore and copper increased in the first quarter, when compared with last year, despite the company scaling back spending. Telecoms firm Vodafone was also in demand as rumours continue to circulate surrounding a possible buy-out of its 45% stake in its US wireless joint venture with Verizon. According to reports this morning, a deal could happen this year as fears about tax obstacles ease. Meanwhile, GlaxoSmithKline was trading lower ahead of its first-quarter update next week. There were reports this morning that the company is being investigated over claims it paid off firms to delay the launch of cheap versions of its anti-depression drug. Heading the other way was supermarket group Tesco, extending losses after its full-year results on Wednesday revealed its first annual profit decline in two decades.FTSE 250: Miners gain, Spectris plummetsAs on the top tier index, miners made gains as investors sought gains after a volatile week for the sector. Bumi, Centamin, Hochschild, and Lonmin all made strong gains by late in the session. However Kazakhmys, which owns a 26% stake in ENRC, was the best performer, tracking the miner higher on takeover speculation.African Barrick Gold was performing well one day after its first-quarter results showed an improved picture. Westhouse Securities reduced its target price for the stock today (reflecting revised gold-price forecasts) but said that the results "suggest a bit more room for optimism" following recent disappointments.Meanwhile, electrical engineering company Spectris reported an eight per cent fall in sales for the first quarter, reflecting a deferral of orders and shipment delays. The group experienced weak customer confidence across all its major regions in the first three months of the year. Sector peer Renishaw fell in sympathy.High Street bookie William Hill surged despite reporting that growth had moderated during the first quarter. The firm did say however that the Grand National after the quarter-end was a "major success", beating its record win achieved on the race in 2009.FTSE 100 - RisersEurasian Natural Resources Corp. (ENRC) 291.00p +26.63%Vedanta Resources (VED) 1,151.00p +6.08%Evraz (EVR) 161.80p +3.45%Fresnillo (FRES) 1,117.00p +2.85%Petrofac Ltd. (PFC) 1,302.00p +2.84%International Consolidated Airlines Group SA (CDI) (IAG) 252.30p +2.60%Royal Bank of Scotland Group (RBS) 280.50p +2.41%HSBC Holdings (HSBA) 679.20p +2.40%Tullow Oil (TLW) 1,048.00p +2.34%Anglo American (AAL) 1,596.50p +2.21%FTSE 100 - FallersIMI (IMI) 1,174.00p -1.59%Wolseley (WOS) 3,133.00p -1.01%Rolls-Royce Holdings (RR.) 1,123.00p -0.80%Tesco (TSCO) 363.00p -0.67%Schroders (SDR) 2,155.00p -0.55%Melrose Industries (MRO) 244.60p -0.53%BG Group (BG.) 1,038.00p -0.48%Capita (CPI) 853.00p -0.47%Aggreko (AGK) 1,769.00p -0.39%GlaxoSmithKline (GSK) 1,652.00p -0.36%FTSE 250 - RisersKazakhmys (KAZ) 385.70p +24.38%African Barrick Gold (ABG) 179.10p +7.96%Bumi (BUMI) 259.30p +7.82%Centamin (DI) (CEY) 38.65p +6.01%Petropavlovsk (POG) 141.40p +5.52%Hochschild Mining (HOC) 242.60p +5.48%William Hill (WMH) 409.10p +4.74%NMC Health (NMC) 340.00p +4.62%Playtech Ltd. (PTEC) 599.00p +3.81%Thomas Cook Group (TCG) 121.50p +3.76%FTSE 250 - FallersSpectris (SXS) 1,908.00p -14.25%Renishaw (RSW) 1,551.00p -5.66%Laird (LRD) 198.00p -5.44%Jupiter Fund Management (JUP) 310.30p -2.61%Fenner (FENR) 354.50p -2.56%Interserve (IRV) 462.50p -2.53%SDL (SDL) 384.20p -2.46%Perform Group (PER) 489.00p -2.40%TalkTalk Telecom Group (TALK) 250.00p -2.31%Kentz Corporation Ltd. (KENZ) 372.70p -2.18%BC
More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.